By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


DURECT Corporation 

2 Results Way

Cupertino  California  95014  U.S.A.
Phone: 408-777-1417 Fax: 408-777-3577



Company News
DURECT Corporation (DRRX) Secures $20 Million Debt Financing 6/27/2014 9:31:40 AM
DURECT Corporation (DRRX) To Present At The Wall Street Analyst Forum Institutional Investor Conference 6/9/2014 10:17:47 AM
DURECT Corporation (DRRX) Announces POSIDUR™ (SABER®-Bupivacaine) Data Presentation At The International Anesthesia Research Society (IARS) Annual Meeting 5/16/2014 7:49:16 AM
DURECT Corporation (DRRX) Announces Participation In Bay Area Prescription Drug Abuse Summit Meeting 5/7/2014 7:51:39 AM
DURECT Corporation (DRRX) Announces First Quarter 2014 Financial Results And Update Of Programs 5/2/2014 8:44:11 AM
DURECT Corporation (DRRX) Announces POSIDUR™ (SABER®-Bupivacaine) Data Presentations At The 39th Annual American Society Of Regional Anesthetic And Pain Medicine Meeting 4/2/2014 6:28:40 AM
DURECT Corporation (DRRX) Announces Fourth Quarter 2013 Financial Results And Update Of Programs 2/28/2014 6:17:47 AM
DURECT Corporation (DRRX) Invites You To Join Its Fourth Quarter 2013 Earnings Conference Call And Upcoming Investor Conference 2/18/2014 7:04:31 AM
FDA Declines To Approve DURECT Corporation (DRRX)'s Pain Drug; Stock Drops -20.51% At Market Close (February 13, 2014) 2/13/2014 6:46:22 AM
IMPAX Laboratories, Inc. (IPXL), DURECT Corporation (DRRX) Strike $63 Million ELADUR® Pain Patch Pledge 1/7/2014 6:57:53 AM